Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(45 sites)
United States
USC Norris Comprehensive Cancer Center, Los Angeles, California Stanford University, Stanford, California MedStar Georgetown University Hospital, Washington D.C., District of Columbia University of Miami Hospital and Clinics Sylvester Comprehensive Cancer Center, Miami, Florida Bleeding and Clotting Disorders Institute, Peoria, Illinois Ochsner Clinical Foundation, New Orleans, Louisiana Mayo Clinic, Rochester, Minnesota Clinical Research Alliance, Westbury, New York Texas Oncology - Central South, Austin, Texas MD Anderson Cancer Center, Houston, Texas Texas Oncology Gulf Coast, The Woodlands, Texas China
Nanfang Hospital of Southern Medical University, Guangzhou Qilu Hospital of Shandong University, Jinan Hematology Hospital of the Chinese Academy of Medical Sciences, Tianjin Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan France
Hôpital Henri Mondor, Créteil CHU Dijon - Hopital du Bocage, Dijon CHU Bordeaux - Hôpital Haut-Lévêque, Pessac Italy
Azienda Ospedaliera Universitaria Policlinico Sant'Orsola Malpighi IRCCS, Bologna Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico, Milan Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma Azienda Sanitaria Universitaria Giuliano Isontina (ASU GI), Trieste Norway
Haukeland University Hospital, Bergen Sykehuset Ostfold, Kalnes, Grålum St. Olavs Hospital Hf, Universitetssykehuset i Trondheim, Trondheim Poland
Pratia Onkologia Katowice, Katowice Pratia MCM Krakow, Krakow Aidport sp z o.o., Skorzewo MICS Centrum Medyczne Torun, Torun Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu, Wroclaw South Korea
Pusan National University Hospital, Busan Seoul National University Hospital, Seoul Severance Hospital, Yonsei University Health System, Seoul Asan Medical Center, Seoul The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul Spain
Hospital Clinic de Barcelona, Barcelona Hospital Universitario de Burgos, Burgos Hospital General Universitario Morales Meseguer, Murcia Clinica Universidad de Navarra, Pamplona United Kingdom
Bristol Haematology and Oncology Centre, Bristol St James's University Hospital, Leeds Leicester Royal Infirmary, Leicester Royal London Hospital, London Hammersmith Hospital, London